[1]
Kwatra, S.G., de Bruin-Weller, M., Silverberg, J.I., Lio, P., Deleuran, M., Aydin, H., Calimlim, B.M., Lane, M.C., Liu, Y., Ofori, S. and Weidinger, S. 2024. Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib. Acta Dermato-Venereologica. 104, (May 2024), adv18452. DOI:https://doi.org/10.2340/actadv.v104.18452.